Skip to main content
. Author manuscript; available in PMC: 2010 Jul 22.
Published in final edited form as: J Allergy Clin Immunol. 2007 Nov;120(5):1178–1185. doi: 10.1016/j.jaci.2007.10.001

FIG 3.

FIG 3

Proliferation of B cells of subjects with C104R TACI mutations. As for Fig 2, proliferation of CFSE (x-axis)–labeled B cells of 3 unrelated subjects with CVID with C104R mutations were compared by using stimulators shown. y-axis = cell counts. A, APRIL alone. B, APRIL + IL-10. C, CD40 ligand + IL-10. D, CpG.

HHS Vulnerability Disclosure